Between the end of the year and spring, the market is indeed prone to stagnation. Without a clear downward break, it's difficult to see trend opportunities, which is also why I previously decided to close early.

If you're still in the market, my advice is simple—be patient and wait. Wait for a real correction to appear before considering phased entries. During sideways consolidation, it's better to stay put than to trade frequently.

This time, in the biotech sector, although I didn't suffer major losses, I also didn't make a big move and even ended up with a 2% loss. Honestly, these hot sectors are really hard to trade; both risk and reward are amplified. Instead of stubbornly holding on, it's better to change your approach.

The current strategy is: leave some positions untouched for now, and when the index shows a clear technical breakdown, consider re-entering for swing trading. Time can buy space; sometimes, it's more cost-effective than blindly chasing the market.